カテゴリー： LP Information, 世界, 医療/バイオ

世界のMRD（最小残存病変）検査市場予測 2021年-2026年

【英語タイトル】Global MRD (Minimal Residual Disease) Testing Market Growth 2021-2026

LP Informationが出版した調査資料（LPI21MY9126）・商品コード：LPI21MY9126
・発行会社（調査会社）：LP Information
・発行日：2021年5月（※2024年版があります。お問い合わせください）
・ページ数：116
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療装置
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥541,680見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥812,520見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,083,360見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
LPインフォメーション社の「MRD（最小残存病変）検査の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、フローサイトメトリー、ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS）など、用途別には、専門クリニック・病院、診断研究所、研究機関などにセグメント区分してまとめました。MRD（最小残存病変）検査のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。
・MRD（最小残存病変）検査の世界市場概要（サマリー）
・MRD（最小残存病変）検査の企業別販売量・売上
・MRD（最小残存病変）検査の企業別市場シェア
・MRD（最小残存病変）検査の世界市場規模 2016年-2021年：種類別（フローサイトメトリー、ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS））
・MRD（最小残存病変）検査の世界市場規模 2016年-2021年：用途別（専門クリニック・病院、診断研究所、研究機関）
・MRD（最小残存病変）検査の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど）
・MRD（最小残存病変）検査のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）
・MRD（最小残存病変）検査のヨーロッパ市場規模（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・MRD（最小残存病変）検査の中東・アフリカ市場（エジプト、南アフリカ、トルコ、GCC諸国など）
・MRD（最小残存病変）検査市場の成長要因・課題・動向
・MRD（最小残存病変）検査の世界市場予測 2021年-2026年
・MRD（最小残存病変）検査の南北アメリカ市場予測（アメリカ、カナダ、メキシコなど）
・MRD（最小残存病変）検査のアジア市場予測（日本、中国、韓国、インド、東南アジアなど）
・MRD（最小残存病変）検査のヨーロッパ市場予測（ドイツ、フランス、イギリス、イタリア、ロシアなど）
・MRD（最小残存病変）検査の中東・アフリカ市場予測（エジプト、南アフリカ、トルコ、GCC諸国など）
・MRD（最小残存病変）検査の世界市場予測：種類別（フローサイトメトリー、ポリメラーゼ連鎖反応（PCR）、次世代シーケンシング（NGS））
・MRD（最小残存病変）検査の世界市場予測：用途別（専門クリニック・病院、診断研究所、研究機関）
・主要企業分析
【レポートの概要】

According to this latest study, the 2021 growth of MRD (Minimal Residual Disease) Testing will have significant change from previous year. By the most conservative estimates of global MRD (Minimal Residual Disease) Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ XX million in 2020. Over the next five years the MRD (Minimal Residual Disease) Testing market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of MRD (Minimal Residual Disease) Testing market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021, in Section 2.3; and forecast to 2026 in section 11.7.
Flow Cytometry
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 11.8.
Specialty Clinics and Hospitals
Diagnostic Laboratories
Research Institutions

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in Chapter 3.
ICON plc
ArcherDX(Invitae)
ARUP Laboratories
Asuragen
Cergentis B.V.
Bio-Rad Laboratories
Mission Bio
Guardant Health
Invivoscribe
LabCorp
Inivata
Natera
NeoGenomics Laboratories
Opko Health
Quest Diagnostics
Sysmex Corporation
Adaptive Biotechnologies

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global MRD (Minimal Residual Disease) Testing Consumption 2016-2026
2.1.2 MRD (Minimal Residual Disease) Testing Consumption CAGR by Region
2.2 MRD (Minimal Residual Disease) Testing Segment by Type
2.2.1 Flow Cytometry
2.2.2 Polymerase Chain Reaction (PCR)
2.2.3 Next-Generation Sequencing (NGS)
2.3 MRD (Minimal Residual Disease) Testing Sales by Type
2.3.1 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2021)
2.3.2 Global MRD (Minimal Residual Disease) Testing Revenue and Market Share by Type (2016-2021)
2.3.3 Global MRD (Minimal Residual Disease) Testing Sale Price by Type (2016-2021)
2.4 MRD (Minimal Residual Disease) Testing Segment by Application
2.4.1 Specialty Clinics and Hospitals
2.4.2 Diagnostic Laboratories
2.4.3 Research Institutions
2.5 MRD (Minimal Residual Disease) Testing Sales by Application
2.5.1 Global MRD (Minimal Residual Disease) Testing Sale Market Share by Application (2016-2021)
2.5.2 Global MRD (Minimal Residual Disease) Testing Revenue and Market Share by Application (2016-2021)
2.5.3 Global MRD (Minimal Residual Disease) Testing Sale Price by Application (2016-2021)

3 Global MRD (Minimal Residual Disease) Testing by Company
3.1 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Company
3.1.1 Global MRD (Minimal Residual Disease) Testing Sales by Company (2019-2021)
3.1.2 Global MRD (Minimal Residual Disease) Testing Sales Market Share by Company (2019-2021)
3.2 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Company
3.2.1 Global MRD (Minimal Residual Disease) Testing Revenue by Company (2019-2021)
3.2.2 Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Company (2019-2021)
3.3 Global MRD (Minimal Residual Disease) Testing Sale Price by Company
3.4 Global Manufacturers MRD (Minimal Residual Disease) Testing Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers MRD (Minimal Residual Disease) Testing Product Location Distribution
3.4.2 Players MRD (Minimal Residual Disease) Testing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 MRD (Minimal Residual Disease) Testing by Region
4.1 Global MRD (Minimal Residual Disease) Testing by Region
4.1.1 Global MRD (Minimal Residual Disease) Testing Sales by Region
4.1.2 Global MRD (Minimal Residual Disease) Testing Revenue by Region
4.2 Americas MRD (Minimal Residual Disease) Testing Sales Growth
4.3 APAC MRD (Minimal Residual Disease) Testing Sales Growth
4.4 Europe MRD (Minimal Residual Disease) Testing Sales Growth
4.5 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Growth

5 Americas
5.1 Americas MRD (Minimal Residual Disease) Testing Sales by Country
5.1.1 Americas MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021)
5.1.2 Americas MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021)
5.2 Americas MRD (Minimal Residual Disease) Testing Sales by Type
5.3 Americas MRD (Minimal Residual Disease) Testing Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC MRD (Minimal Residual Disease) Testing Sales by Region
6.1.1 APAC MRD (Minimal Residual Disease) Testing Sales by Region (2016-2021)
6.1.2 APAC MRD (Minimal Residual Disease) Testing Revenue by Region (2016-2021)
6.2 APAC MRD (Minimal Residual Disease) Testing Sales by Type
6.3 APAC MRD (Minimal Residual Disease) Testing Sales by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe MRD (Minimal Residual Disease) Testing by Country
7.1.1 Europe MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021)
7.1.2 Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021)
7.2 Europe MRD (Minimal Residual Disease) Testing Sales by Type
7.3 Europe MRD (Minimal Residual Disease) Testing Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa MRD (Minimal Residual Disease) Testing by Country
8.1.1 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021)
8.1.2 Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021)
8.2 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Type
8.3 Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Country

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 MRD (Minimal Residual Disease) Testing Distributors
10.3 MRD (Minimal Residual Disease) Testing Customer

11 Global MRD (Minimal Residual Disease) Testing Market Forecast
11.1 Global MRD (Minimal Residual Disease) Testing Forecast by Region
11.1.1 Global MRD (Minimal Residual Disease) Testing Forecast by Regions (2021-2026)
11.2.2 Global MRD (Minimal Residual Disease) Testing Revenue Forecast by Regions (2021-2026)
11.2 Americas Forecast by Country
11.3 APAC Forecast by Region
11.4 Europe Forecast by Country
11.5 Middle East & Africa Forecast by Country
11.6 Global MRD (Minimal Residual Disease) Testing Forecast by Type
11.7 Global MRD (Minimal Residual Disease) Testing Forecast by Application

12 Key Players Analysis
12.1 ICON plc
12.1.1 ICON plc Company Information
12.1.2 ICON plc MRD (Minimal Residual Disease) Testing Product Offered
12.1.3 ICON plc MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.1.4 ICON plc Main Business Overview
12.1.5 ICON plc Latest Developments
12.2 ArcherDX(Invitae)
12.2.1 ArcherDX(Invitae) Company Information
12.2.2 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Offered
12.2.3 ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.2.4 ArcherDX(Invitae) Main Business Overview
12.2.5 ArcherDX(Invitae) Latest Developments
12.3 ARUP Laboratories
12.3.1 ARUP Laboratories Company Information
12.3.2 ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Offered
12.3.3 ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.3.4 ARUP Laboratories Main Business Overview
12.3.5 ARUP Laboratories Latest Developments
12.4 Asuragen
12.4.1 Asuragen Company Information
12.4.2 Asuragen MRD (Minimal Residual Disease) Testing Product Offered
12.4.3 Asuragen MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.4.4 Asuragen Main Business Overview
12.4.5 Asuragen Latest Developments
12.5 Cergentis B.V.
12.5.1 Cergentis B.V. Company Information
12.5.2 Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Offered
12.5.3 Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.5.4 Cergentis B.V. Main Business Overview
12.5.5 Cergentis B.V. Latest Developments
12.6 Bio-Rad Laboratories
12.6.1 Bio-Rad Laboratories Company Information
12.6.2 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Offered
12.6.3 Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.6.4 Bio-Rad Laboratories Main Business Overview
12.6.5 Bio-Rad Laboratories Latest Developments
12.7 Mission Bio
12.7.1 Mission Bio Company Information
12.7.2 Mission Bio MRD (Minimal Residual Disease) Testing Product Offered
12.7.3 Mission Bio MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.7.4 Mission Bio Main Business Overview
12.7.5 Mission Bio Latest Developments
12.8 Guardant Health
12.8.1 Guardant Health Company Information
12.8.2 Guardant Health MRD (Minimal Residual Disease) Testing Product Offered
12.8.3 Guardant Health MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.8.4 Guardant Health Main Business Overview
12.8.5 Guardant Health Latest Developments
12.9 Invivoscribe
12.9.1 Invivoscribe Company Information
12.9.2 Invivoscribe MRD (Minimal Residual Disease) Testing Product Offered
12.9.3 Invivoscribe MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.9.4 Invivoscribe Main Business Overview
12.9.5 Invivoscribe Latest Developments
12.10 LabCorp
12.10.1 LabCorp Company Information
12.10.2 LabCorp MRD (Minimal Residual Disease) Testing Product Offered
12.10.3 LabCorp MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.10.4 LabCorp Main Business Overview
12.10.5 LabCorp Latest Developments
12.11 Inivata
12.11.1 Inivata Company Information
12.11.2 Inivata MRD (Minimal Residual Disease) Testing Product Offered
12.11.3 Inivata MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.11.4 Inivata Main Business Overview
12.11.5 Inivata Latest Developments
12.12 Natera
12.12.1 Natera Company Information
12.12.2 Natera MRD (Minimal Residual Disease) Testing Product Offered
12.12.3 Natera MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.12.4 Natera Main Business Overview
12.12.5 Natera Latest Developments
12.13 NeoGenomics Laboratories
12.13.1 NeoGenomics Laboratories Company Information
12.13.2 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Offered
12.13.3 NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.13.4 NeoGenomics Laboratories Main Business Overview
12.13.5 NeoGenomics Laboratories Latest Developments
12.14 Opko Health
12.14.1 Opko Health Company Information
12.14.2 Opko Health MRD (Minimal Residual Disease) Testing Product Offered
12.14.3 Opko Health MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.14.4 Opko Health Main Business Overview
12.14.5 Opko Health Latest Developments
12.15 Quest Diagnostics
12.15.1 Quest Diagnostics Company Information
12.15.2 Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Offered
12.15.3 Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.15.4 Quest Diagnostics Main Business Overview
12.15.5 Quest Diagnostics Latest Developments
12.16 Sysmex Corporation
12.16.1 Sysmex Corporation Company Information
12.16.2 Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Offered
12.16.3 Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.16.4 Sysmex Corporation Main Business Overview
12.16.5 Sysmex Corporation Latest Developments
12.17 Adaptive Biotechnologies
12.17.1 Adaptive Biotechnologies Company Information
12.17.2 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Offered
12.17.3 Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales, Revenue, Price and Gross Margin (2019-2021)
12.17.4 Adaptive Biotechnologies Main Business Overview
12.17.5 Adaptive Biotechnologies Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. MRD (Minimal Residual Disease) Testing Consumption CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Flow Cytometry
Table 3. Major Players of Polymerase Chain Reaction (PCR)
Table 4. Major Players of Next-Generation Sequencing (NGS)
Table 5. Global MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021) & (Units)
Table 6. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2021)
Table 7. Global MRD (Minimal Residual Disease) Testing Revenue by Type (2016-2021) & ($ million)
Table 8. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2016-2021)
Table 9. Global MRD (Minimal Residual Disease) Testing Sale Price by Type (2016-2021)
Table 10. Global MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021) & (Units)
Table 11. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2021)
Table 12. Global MRD (Minimal Residual Disease) Testing Value by Application (2016-2021)
Table 13. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Application (2016-2021)
Table 14. Global MRD (Minimal Residual Disease) Testing Sale Price by Application (2016-2021)
Table 15. Global MRD (Minimal Residual Disease) Testing Sales by Company (2019-2021) & (Units)
Table 16. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Company (2019-2021)
Table 17. Global MRD (Minimal Residual Disease) Testing Revenue by Company (2019-2021) ($ Millions)
Table 18. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Company (2019-2021)
Table 19. Global MRD (Minimal Residual Disease) Testing Sale Price by Company (2019-2021)
Table 20. Key Manufacturers MRD (Minimal Residual Disease) Testing Producing Area Distribution and Sales Area
Table 21. Players MRD (Minimal Residual Disease) Testing Products Offered
Table 22. MRD (Minimal Residual Disease) Testing Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global MRD (Minimal Residual Disease) Testing Sales by Region (2016-2021) (Units)
Table 26. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2016-2021)
Table 27. Global MRD (Minimal Residual Disease) Testing Revenue by Region (2016-2021) & ($ Millions)
Table 28. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Region (2016-2021)
Table 29. Americas MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021) & (Units)
Table 30. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2016-2021)
Table 31. Americas MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021) & ($ Millions)
Table 32. Americas MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2016-2021)
Table 33. Americas MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021) & (Units)
Table 34. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2021)
Table 35. Americas MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021) & (Units)
Table 36. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2021)
Table 37. APAC MRD (Minimal Residual Disease) Testing Sales by Region (2016-2021) & (Units)
Table 38. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Region (2016-2021)
Table 39. APAC MRD (Minimal Residual Disease) Testing Revenue by Region (2016-2021) & ($ Millions)
Table 40. APAC MRD (Minimal Residual Disease) Testing Revenue Market Share by Region (2016-2021)
Table 41. APAC MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021) & (Units)
Table 42. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2021)
Table 43. APAC MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021) & (Units)
Table 44. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2021)
Table 45. Europe MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021) & (Units)
Table 46. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2016-2021)
Table 47. Europe MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021) & ($ Millions)
Table 48. Europe MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2016-2021)
Table 49. Europe MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021) & (Units)
Table 50. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2021)
Table 51. Europe MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021) & (Units)
Table 52. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2021)
Table 53. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Country (2016-2021) & (Units)
Table 54. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Country (2016-2021)
Table 55. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue by Country (2016-2021) & ($ Millions)
Table 56. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue Market Share by Country (2016-2021)
Table 57. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Type (2016-2021) & (Units)
Table 58. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Type (2016-2021)
Table 59. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales by Application (2016-2021) & (Units)
Table 60. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2021)
Table 61. Key and Potential Regions of MRD (Minimal Residual Disease) Testing
Table 62. Key Application and Potential Industries of MRD (Minimal Residual Disease) Testing
Table 63. Key Challenges of MRD (Minimal Residual Disease) Testing
Table 64. Key Trends of MRD (Minimal Residual Disease) Testing
Table 65. MRD (Minimal Residual Disease) Testing Distributors List
Table 66. MRD (Minimal Residual Disease) Testing Customer List
Table 67. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Region (2021-2026) & (Units)
Table 68. Global MRD (Minimal Residual Disease) Testing Consumption Market Forecast by Region
Table 69. Global MRD (Minimal Residual Disease) Testing Revenue Forecast by Region (2021-2026) & ($ millions)
Table 70. Global MRD (Minimal Residual Disease) Testing Revenue Market Share Forecast by Region (2021-2026)
Table 71. Americas MRD (Minimal Residual Disease) Testing Sales Forecast by Country (2021-2026) & (Units)
Table 72. Americas MRD (Minimal Residual Disease) Testing Revenue Forecast by Country (2021-2026) & ($ millions)
Table 73. APAC MRD (Minimal Residual Disease) Testing Sales Forecast by Region (2021-2026) & (Units)
Table 74. APAC MRD (Minimal Residual Disease) Testing Revenue Forecast by Region (2021-2026) & ($ millions)
Table 75. Europe MRD (Minimal Residual Disease) Testing Sales Forecast by Country (2021-2026) & (Units)
Table 76. Europe MRD (Minimal Residual Disease) Testing Revenue Forecast by Country (2021-2026) & ($ millions)
Table 77. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Forecast by Country (2021-2026) & (Units)
Table 78. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue Forecast by Country (2021-2026) & ($ millions)
Table 79. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Type (2021-2026) & (Units)
Table 80. Global MRD (Minimal Residual Disease) Testing Sales Market Share Forecast by Type (2021-2026)
Table 81. Global MRD (Minimal Residual Disease) Testing Revenue Forecast by Type (2021-2026) & ($ Millions)
Table 82. Global MRD (Minimal Residual Disease) Testing Revenue Market Share Forecast by Type (2021-2026)
Table 83. Global MRD (Minimal Residual Disease) Testing Sales Forecast by Application (2021-2026) & (Units)
Table 84. Global MRD (Minimal Residual Disease) Testing Sales Market Share Forecast by Application (2021-2026)
Table 85. Global MRD (Minimal Residual Disease) Testing Revenue Forecast by Application (2021-2026) & ($ Millions)
Table 86. Global MRD (Minimal Residual Disease) Testing Revenue Market Share Forecast by Application (2021-2026)
Table 87. ICON plc Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 88. ICON plc MRD (Minimal Residual Disease) Testing Product Offered
Table 89. ICON plc MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 90. ICON plc Main Business
Table 91. ICON plc Latest Developments
Table 92. ArcherDX(Invitae) Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 93. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Product Offered
Table 94. ArcherDX(Invitae) MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 95. ArcherDX(Invitae) Main Business
Table 96. ArcherDX(Invitae) Latest Developments
Table 97. ARUP Laboratories Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 98. ARUP Laboratories MRD (Minimal Residual Disease) Testing Product Offered
Table 99. ARUP Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 100. ARUP Laboratories Main Business
Table 101. ARUP Laboratories Latest Developments
Table 102. Asuragen Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 103. Asuragen MRD (Minimal Residual Disease) Testing Product Offered
Table 104. Asuragen MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 105. Asuragen Main Business
Table 106. Asuragen Latest Developments
Table 107. Cergentis B.V. Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 108. Cergentis B.V. MRD (Minimal Residual Disease) Testing Product Offered
Table 109. Cergentis B.V. MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 110. Cergentis B.V. Main Business
Table 111. Cergentis B.V. Latest Developments
Table 112. Bio-Rad Laboratories Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 113. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Product Offered
Table 114. Bio-Rad Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 115. Bio-Rad Laboratories Main Business
Table 116. Bio-Rad Laboratories Latest Developments
Table 117. Mission Bio Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 118. Mission Bio MRD (Minimal Residual Disease) Testing Product Offered
Table 119. Mission Bio MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 120. Mission Bio Main Business
Table 121. Mission Bio Latest Developments
Table 122. Guardant Health Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 123. Guardant Health MRD (Minimal Residual Disease) Testing Product Offered
Table 124. Guardant Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 125. Guardant Health Main Business
Table 126. Guardant Health Latest Developments
Table 127. Invivoscribe Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 128. Invivoscribe MRD (Minimal Residual Disease) Testing Product Offered
Table 129. Invivoscribe MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 130. Invivoscribe Main Business
Table 131. Invivoscribe Latest Developments
Table 132. LabCorp Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 133. LabCorp MRD (Minimal Residual Disease) Testing Product Offered
Table 134. LabCorp MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 135. LabCorp Main Business
Table 136. LabCorp Latest Developments
Table 137. Inivata Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 138. Inivata MRD (Minimal Residual Disease) Testing Product Offered
Table 139. Inivata MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 140. Inivata Main Business
Table 141. Inivata Latest Developments
Table 142. Natera Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 143. Natera MRD (Minimal Residual Disease) Testing Product Offered
Table 144. Natera MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 145. Natera Main Business
Table 146. Natera Latest Developments
Table 147. NeoGenomics Laboratories Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 148. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Product Offered
Table 149. NeoGenomics Laboratories MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 150. NeoGenomics Laboratories Main Business
Table 151. NeoGenomics Laboratories Latest Developments
Table 152. Opko Health Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 153. Opko Health MRD (Minimal Residual Disease) Testing Product Offered
Table 154. Opko Health MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 155. Opko Health Main Business
Table 156. Opko Health Latest Developments
Table 157. Quest Diagnostics Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 158. Quest Diagnostics MRD (Minimal Residual Disease) Testing Product Offered
Table 159. Quest Diagnostics MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 160. Quest Diagnostics Main Business
Table 161. Quest Diagnostics Latest Developments
Table 162. Sysmex Corporation Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 163. Sysmex Corporation MRD (Minimal Residual Disease) Testing Product Offered
Table 164. Sysmex Corporation MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 165. Sysmex Corporation Main Business
Table 166. Sysmex Corporation Latest Developments
Table 167. Adaptive Biotechnologies Basic Information, MRD (Minimal Residual Disease) Testing Manufacturing Base, Sales Area and Its Competitors
Table 168. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Product Offered
Table 169. Adaptive Biotechnologies MRD (Minimal Residual Disease) Testing Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E)
Table 170. Adaptive Biotechnologies Main Business
Table 171. Adaptive Biotechnologies Latest Developments
List of Figures
Figure 1. Picture of MRD (Minimal Residual Disease) Testing
Figure 2. MRD (Minimal Residual Disease) Testing Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global MRD (Minimal Residual Disease) Testing Sales Growth Rate 2016-2026 (Units)
Figure 7. Global MRD (Minimal Residual Disease) Testing Revenue Growth Rate 2016-2026 ($ Millions)
Figure 8. MRD (Minimal Residual Disease) Testing Sales by Region (2021 & 2026) & ($ millions)
Figure 9. Product Picture of Flow Cytometry
Figure 10. Product Picture of Polymerase Chain Reaction (PCR)
Figure 11. Product Picture of Next-Generation Sequencing (NGS)
Figure 12. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Type in 2020
Figure 13. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Type (2016-2021)
Figure 14. MRD (Minimal Residual Disease) Testing Consumed in Specialty Clinics and Hospitals
Figure 15. Global MRD (Minimal Residual Disease) Testing Market: Specialty Clinics and Hospitals (2016-2021) & (Units)
Figure 16. MRD (Minimal Residual Disease) Testing Consumed in Diagnostic Laboratories
Figure 17. Global MRD (Minimal Residual Disease) Testing Market: Diagnostic Laboratories (2016-2021) & (Units)
Figure 18. MRD (Minimal Residual Disease) Testing Consumed in Research Institutions
Figure 19. Global MRD (Minimal Residual Disease) Testing Market: Research Institutions (2016-2021) & (Units)
Figure 20. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Application (2016-2021)
Figure 21. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Application in 2020
Figure 22. MRD (Minimal Residual Disease) Testing Revenue Market by Company in 2020 ($ Million)
Figure 23. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Company in 2020
Figure 24. Global MRD (Minimal Residual Disease) Testing Sales Market Share by Regions (2016-2021)
Figure 25. Global MRD (Minimal Residual Disease) Testing Revenue Market Share by Region in 2020
Figure 26. Americas MRD (Minimal Residual Disease) Testing Sales 2016-2021 (Units)
Figure 27. Americas MRD (Minimal Residual Disease) Testing Revenue 2016-2021 ($ Millions)
Figure 28. APAC MRD (Minimal Residual Disease) Testing Sales 2016-2021 (Units)
Figure 29. APAC MRD (Minimal Residual Disease) Testing Revenue 2016-2021 ($ Millions)
Figure 30. Europe MRD (Minimal Residual Disease) Testing Sales 2016-2021 (Units)
Figure 31. Europe MRD (Minimal Residual Disease) Testing Revenue 2016-2021 ($ Millions)
Figure 32. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales 2016-2021 (Units)
Figure 33. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue 2016-2021 ($ Millions)
Figure 34. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Country in 2020
Figure 35. Americas MRD (Minimal Residual Disease) Testing Revenue Market Share by Country in 2020
Figure 36. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Type in 2020
Figure 37. Americas MRD (Minimal Residual Disease) Testing Sales Market Share by Application in 2020
Figure 38. United States MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 39. Canada MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 40. Mexico MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 41. Brazil MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 42. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Region in 2020
Figure 43. APAC MRD (Minimal Residual Disease) Testing Revenue Market Share by Regions in 2020
Figure 44. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Type in 2020
Figure 45. APAC MRD (Minimal Residual Disease) Testing Sales Market Share by Application in 2020
Figure 46. China MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 47. Japan MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 48. Korea MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 49. Southeast Asia MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 50. India MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 51. Australia MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 52. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Country in 2020
Figure 53. Europe MRD (Minimal Residual Disease) Testing Revenue Market Share by Country in 2020
Figure 54. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Type in 2020
Figure 55. Europe MRD (Minimal Residual Disease) Testing Sales Market Share by Application in 2020
Figure 56. Germany MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 57. France MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 58. UK MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 59. Italy MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 60. Russia MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 61. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Country in 2020
Figure 62. Middle East & Africa MRD (Minimal Residual Disease) Testing Revenue Market Share by Country in 2020
Figure 63. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Type in 2020
Figure 64. Middle East & Africa MRD (Minimal Residual Disease) Testing Sales Market Share by Application in 2020
Figure 65. Egypt MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 66. South Africa MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 67. Israel MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 68. Turkey MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 69. GCC Country MRD (Minimal Residual Disease) Testing Revenue Growth 2016-2021 ($ Millions)
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles


★調査レポート[世界のMRD（最小残存病変）検査市場予測 2021年-2026年] (コード：LPI21MY9126)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のMRD（最小残存病変）検査市場予測 2021年-2026年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の疾病検査用口腔液収集チューブ市場予測 2021年-2026年
    LPI21MY9167 / LP Information / 2021年5月 / LPインフォメーション社の「疾病検査用口腔液収集チューブの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、唾液チューブ、口腔スポンジなど、用途別には、一般分析用、ゲノム分析用などにセグメント区分してまとめました。疾病検査用口腔液収集チューブのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・疾病検査用口腔液収集チューブの世界市場概要（サマリー） ・疾病検査用口腔液収集チューブの企業別販売量・売上 ・疾病検査用口腔液収集チューブの企業別市場シェア ・疾病検査用口腔液収集チューブの世界市場規模 2016年-2021年：種類別（唾液チューブ、口腔スポンジ） ・疾病検査用口腔液収集チューブの世界市場規模 2016年-2021年：用途別（一般分析用、ゲノム分析用） ・疾病検査用口腔液収集チューブの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・疾病検査用口腔液収集チューブのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Oral Fluid Collection Tubes for Disease Testing will have significant change from previous year. By the most conservative estimates of global Oral Fluid Collection Tubes for Disease Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Oral Fluid Collection Tubes for Disease Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market...
  • 世界の残留塩素計市場予測 2021年-2026年
    LPI21MY6933 / LP Information / 2021年5月 / LPインフォメーション社の「残留塩素計の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、LEDディスプレイ、LCDディスプレイなど、用途別には、工業用、実験室用、その他などにセグメント区分してまとめました。残留塩素計のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・残留塩素計の世界市場概要（サマリー） ・残留塩素計の企業別販売量・売上 ・残留塩素計の企業別市場シェア ・残留塩素計の世界市場規模 2016年-2021年：種類別（LEDディスプレイ、LCDディスプレイ） ・残留塩素計の世界市場規模 2016年-2021年：用途別（工業用、実験室用、その他） ・残留塩素計の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・残留塩素計のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Residual Chlorine Meters will have significant change from previous year. By the most conservative estimates of global Residual Chlorine Meters market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Residual Chlorine Meters market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Residual Chlorine Meters market by product type,...
  • 世界の残留塩素分析装置市場予測 2021年-2026年
    LPI21MY6932 / LP Information / 2021年5月 / LPインフォメーション社の「残留塩素分析装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ポータブル残留塩素分析装置、オンライン残留塩素分析装置など、用途別には、石油＆ガス、水＆廃水、石油化学、環境、その他などにセグメント区分してまとめました。残留塩素分析装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・残留塩素分析装置の世界市場概要（サマリー） ・残留塩素分析装置の企業別販売量・売上 ・残留塩素分析装置の企業別市場シェア ・残留塩素分析装置の世界市場規模 2016年-2021年：種類別（ポータブル残留塩素分析装置、オンライン残留塩素分析装置） ・残留塩素分析装置の世界市場規模 2016年-2021年：用途別（石油＆ガス、水＆廃水、石油化学、環境、その他） ・残留塩素分析装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・残留塩素分析装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Residual Chlorine Analyzers will have significant change from previous year. By the most conservative estimates of global Residual Chlorine Analyzers market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Residual Chlorine Analyzers market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Residual Chlorine Analyzers market by product type,...
  • 世界の職場内検査用口腔液収集チューブ市場予測 2021年-2026年
    LPI21MY9168 / LP Information / 2021年5月 / LPインフォメーション社の「職場内検査用口腔液収集チューブの世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、唾液チューブ、口腔スポンジなど、用途別には、一般分析用、ゲノム分析用などにセグメント区分してまとめました。職場内検査用口腔液収集チューブのグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・職場内検査用口腔液収集チューブの世界市場概要（サマリー） ・職場内検査用口腔液収集チューブの企業別販売量・売上 ・職場内検査用口腔液収集チューブの企業別市場シェア ・職場内検査用口腔液収集チューブの世界市場規模 2016年-2021年：種類別（唾液チューブ、口腔スポンジ） ・職場内検査用口腔液収集チューブの世界市場規模 2016年-2021年：用途別（一般分析用、ゲノム分析用） ・職場内検査用口腔液収集チューブの南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・職場内検査用口腔液収集チューブのアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Oral Fluid Collection Tubes for Workplace Testing will have significant change from previous year. By the most conservative estimates of global Oral Fluid Collection Tubes for Workplace Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Oral Fluid Collection Tubes for Workplace Testing market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market...
  • 世界のハンセン病治療薬市場予測 2021年-2026年
    LPI21MY9549 / LP Information / 2021年5月 / LPインフォメーション社の「ハンセン病治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、クロファジミン、サリドマイド、その他など、用途別には、病院、クリニック、その他などにセグメント区分してまとめました。ハンセン病治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ハンセン病治療薬の世界市場概要（サマリー） ・ハンセン病治療薬の企業別販売量・売上 ・ハンセン病治療薬の企業別市場シェア ・ハンセン病治療薬の世界市場規模 2016年-2021年：種類別（クロファジミン、サリドマイド、その他） ・ハンセン病治療薬の世界市場規模 2016年-2021年：用途別（病院、クリニック、その他） ・ハンセン病治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ハンセン病治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2021 growth of Hansen's Disease Therapeutics will have significant change from previous year. By the most conservative estimates of global Hansen's Disease Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the Hansen's Disease Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026. This report presents a comprehensive overview, market shares, and growth opportunities of Hansen's Disease Therapeutics market by product type,...
  • 世界の糖尿病性眼疾患用装置市場予測 2021年-2026年
    LPI21MY8906 / LP Information / 2021年5月 / LPインフォメーション社の「糖尿病性眼疾患用装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、レーザー手術、硝子体切除術など、用途別には、病院、クリニック、その他などにセグメント区分してまとめました。糖尿病性眼疾患用装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・糖尿病性眼疾患用装置の世界市場概要（サマリー） ・糖尿病性眼疾患用装置の企業別販売量・売上 ・糖尿病性眼疾患用装置の企業別市場シェア ・糖尿病性眼疾患用装置の世界市場規模 2016年-2021年：種類別（レーザー手術、硝子体切除術） ・糖尿病性眼疾患用装置の世界市場規模 2016年-2021年：用途別（病院、クリニック、その他） ・糖尿病性眼疾患用装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・糖尿病性眼疾患用装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Diabetic Eye Disease Devices will have significant change from previous year. By the most conservative estimates of global Diabetic Eye Disease Devices market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Diabetic Eye Disease Devices market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Diabetic Eye Disease Devices...
  • 世界のゴーシェ病治療薬市場予測 2021年-2026年
    LPI21MY9538 / LP Information / 2021年5月 / LPインフォメーション社の「ゴーシェ病治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、酵素、グルコシルセラミドシンターゼ阻害剤、骨粗鬆症治療薬など、用途別には、I型ゴーシェ病、II型ゴーシェ病、III型ゴーシェ病などにセグメント区分してまとめました。ゴーシェ病治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・ゴーシェ病治療薬の世界市場概要（サマリー） ・ゴーシェ病治療薬の企業別販売量・売上 ・ゴーシェ病治療薬の企業別市場シェア ・ゴーシェ病治療薬の世界市場規模 2016年-2021年：種類別（酵素、グルコシルセラミドシンターゼ阻害剤、骨粗鬆症治療薬） ・ゴーシェ病治療薬の世界市場規模 2016年-2021年：用途別（I型ゴーシェ病、II型ゴーシェ病、III型ゴーシェ病） ・ゴーシェ病治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・ゴーシェ病治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Gaucher Disease Drugs will have significant change from previous year. By the most conservative estimates of global Gaucher Disease Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 1292.3 million in 2019. Over the next five years the Gaucher Disease Drugs market will register a 0.6% CAGR in terms of revenue, the global market size will reach US$ 1326.1 million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Gaucher Disease Drugs market by product type,...
  • 世界の臨床用イムノアッセイ分析装置市場予測 2021年-2026年
    LPI21MY8837 / LP Information / 2021年5月 / LPインフォメーション社の「臨床用イムノアッセイ分析装置の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、腫瘍・内分泌、肝炎・レトロウイルス検査、心臓病、感染症検査、治療薬モニタリング、消化管検査など、用途別には、病院、臨床診断研究所、研究・学術研究所、その他などにセグメント区分してまとめました。臨床用イムノアッセイ分析装置のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・臨床用イムノアッセイ分析装置の世界市場概要（サマリー） ・臨床用イムノアッセイ分析装置の企業別販売量・売上 ・臨床用イムノアッセイ分析装置の企業別市場シェア ・臨床用イムノアッセイ分析装置の世界市場規模 2016年-2021年：種類別（腫瘍・内分泌、肝炎・レトロウイルス検査、心臓病、感染症検査、治療薬モニタリング、消化管検査） ・臨床用イムノアッセイ分析装置の世界市場規模 2016年-2021年：用途別（病院、臨床診断研究所、研究・学術研究所、その他） ・臨床用イムノアッセイ分析装置の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・臨床用イムノアッセイ分析装置のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Clinical Immunoassay Analyzers will have significant change from previous year. By the most conservative estimates of global Clinical Immunoassay Analyzers market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Clinical Immunoassay Analyzers market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Immunoassay Analyzers market by product type,...
  • 世界の心血管疾患治療薬市場予測 2021年-2026年
    LPI21MY9466 / LP Information / 2021年5月 / LPインフォメーション社の「心血管疾患治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、ヘパリン、クマディン、セクトラル、ゼベタ、ロプレッサー、トプロロールXL、ノルバスク、ロットレル、その他など、用途別には、虚血性心疾患、脂質異常症、脳卒中、血栓症、アテローム性動脈硬化症、冠状動脈疾患、末梢動脈疾患、その他などにセグメント区分してまとめました。心血管疾患治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・心血管疾患治療薬の世界市場概要（サマリー） ・心血管疾患治療薬の企業別販売量・売上 ・心血管疾患治療薬の企業別市場シェア ・心血管疾患治療薬の世界市場規模 2016年-2021年：種類別（ヘパリン、クマディン、セクトラル、ゼベタ、ロプレッサー、トプロロールXL、ノルバスク、ロットレル、その他） ・心血管疾患治療薬の世界市場規模 2016年-2021年：用途別（虚血性心疾患、脂質異常症、脳卒中、血栓症、アテローム性動脈硬化症、冠状動脈疾患、末梢動脈疾患、その他） ・心血管疾患治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・心血管疾患治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Cardiovascular Disease Drugs will have significant change from previous year. By the most conservative estimates of global Cardiovascular Disease Drugs market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Cardiovascular Disease Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Cardiovascular Disease Drugs market by product type,...
  • 世界の希少疾患治療薬市場予測 2021年-2026年
    LPI21MY9563 / LP Information / 2021年5月 / LPインフォメーション社の「希少疾患治療薬の世界市場」調査資料は、南北アメリカ、アジア、ヨーロッパ、中東・アフリカ市場を対象にしており、種類別には、1‰以上、0.65‰〜1‰、0.1‰以下など、用途別には、病院薬局、専門薬局、小売薬局、その他などにセグメント区分してまとめました。希少疾患治療薬のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が掲載されています。 ・希少疾患治療薬の世界市場概要（サマリー） ・希少疾患治療薬の企業別販売量・売上 ・希少疾患治療薬の企業別市場シェア ・希少疾患治療薬の世界市場規模 2016年-2021年：種類別（1‰以上、0.65‰〜1‰、0.1‰以下） ・希少疾患治療薬の世界市場規模 2016年-2021年：用途別（病院薬局、専門薬局、小売薬局、その他） ・希少疾患治療薬の南北アメリカ市場規模（アメリカ、カナダ、メキシコなど） ・希少疾患治療薬のアジア市場規模（日本、中国、韓国、インド、東南アジアなど）...According to this latest study, the 2020 growth of Rare Disease Drug will have significant change from previous year. By the most conservative estimates of global Rare Disease Drug market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. Over the next five years the Rare Disease Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2025. This report presents a comprehensive overview, market shares, and growth opportunities of Rare Disease Drug market by product type,...

    • ◆H&Iグローバルリサーチのお客様（例）◆